Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
7,125
datasets available to search
ShareScore release 0.7.1
Dataset results
7,125 results for “prostate cancer”
Cisplatin enhances cell stiffness and decreases invasiveness rate in prostate cancer cells by actin accumulation: Confocal and atomic force microscopy
<p><strong>Summary</strong></p> <p>Dataset of imaging data related to the publication Raudenska, M., Kratochvilova, M., Vicar, T., Gumulec, J., Balvan, J., Polanska, H. Pribyl, J. & Masarik, M.:Cisplatin enhances cell stiffness and decreases invasiveness rate in prostate cancer cells by actin accumulation. <em>Scientific Reports </em><strong>2019, </strong>9, 1660</p> <p>This dataset includes image data of <em>atomic force microcopy</em> (Young modulus) and <em>confocal microscopy</em>(staining of F-actin and β-tubulin) of prostate cell lines PNT1A, 22Rv1, and PC-3. </p> <p><strong>Materials and Methods</strong></p> <p><em>Cells, cell culture conditions</em></p> <p>Cells confluent up to 50–60% were washed with a FBS-free medium and treated with a fresh medium with FBS and required antineoplastic drug concentration (IC50 concentration for the particular cell line). The cells were treated with 93 µM (PC-3), 38 µM (PNT1A), and 24 µM (22Rv1) of cisplatin (Sigma-Aldrich, St. Louis, Missouri), respectively. IC50 concentrations used for treatment with docetaxel (Sigma-Aldrich, St. Louis, Missouri) were 200nM for PC-3, 70nM for PNT1A, and 150nM for 22Rv1. </p> <p><em>Long-term zinc (II) treatment of cell cultures</em></p> <p>Cells were cultivated in the constant presence of zinc(II) ions. Concentrations of zinc(II) sulphate in the medium were increased gradually by small changes of 25 or 50 µM. The cells were cultivated at each concentration no less than one week before harvesting and their viability was checked before adding more zinc. This process was used to select zinc resistant cells naturally and to ensure better accumulation of zinc within the cells (accumulation of zinc is usually poor during the short-term treatment of prostate cancer cells). Total time of the cultivation of cell lines in the zinc(II)-containing media exceeded one year. Resulting concentrations of zinc(II) in the media (IC50 for the particular cell line) were 50 µM for the PC-3 cell line, 150 µM for the PNT1A cell line, and 400 µM for the 22Rv1 cell line. The concentrations of zinc(II) in the media and FBS were taken into account. </p> <p><em>Actin and tubulin staining</em></p> <p>β-tubulin was labeled with anti- β tubulin antibody [EPR1330] (ab108342) at a working dilution of 1/300. The secondary antibody used was Alexa Fluor® 555 donkey anti-rabbit (ab150074) at a dilution of 1/1000. Actin was labeled with Alexa Fluor™ 488 Phalloidin (A12379, Invitrogen); 1 unit per slide. For mounting Duolink® In Situ Mounting Medium with DAPI (DUO82040) was used. The cells were fixed in 3.7% paraformaldehyde and permeabilized using 0.1% Triton X-100. </p> <p><em>Confocal microscopy</em></p> <p>The microscopy of samples was performed at the Institute of Biophysics, Czech Academy of Sciences, Brno, Czech Republic. Leica DM RXA microscope (equipped with DMSTC motorized stage, Piezzo z-movement, MicroMax CCD camera, CSU-10 confocal unit and 488, 562, and 714 nm laser diodes with AOTF) was used for acquiring detailed cell images (100× oil immersion Plan Fluotar lens, NA 1.3). Total 50 Z slices was captured with Z step size 0.3 μm.</p> <p><em>Atomic force microscopy</em></p> <p>We used the bioAFM microscope JPK NanoWizard 3 (JPK, Berlin, Germany) placed on the inverted optical microscope Olympus IX‑81 (Olympus, Tokyo, Japan) equipped with the fluorescence and confocal module, thus allowing a combined experiment (AFM‑optical combined images). The maximal scanning range of the AFM microscope in X‑Y‑Z range was 100‑100‑15 µm. The typical approach/retract settings were identical with a 15 μm extend/retract length, Setpoint value of 1 nN, a pixel rate of 2048 Hz and a speed of 30 µm/s. The system operated under closed-loop control. After reaching the selected contact force, the cantilever was retracted. The retraction length of 15 μm was sufficient to overcome any adhesion between the tip and the sample and to make sure that the cantilever had been completely retracted from the sample surface. Force‑distance (FD) curve was recorded at each point of the cantilever approach/retract movement. AFM measurements were obtained at 37°C (Petri dish heater, JPK) with force measurements recorded at a pulling speed of 30 µm/s (extension time 0.5 sec).</p> <p>The Young's modulus (E) was calculated by fitting the Hertzian‑Sneddon model on the FD curves measured as force maps (64x64 points) of the region containing either a single cell or multiple cells. JPK data evaluation software was used for the batch processing of measured data. The adjustment of the cantilever position above the sample was carried out under the microscope by controlling the position of the AFM‑head by motorized stage equipped with Petri dish heater (JPK) allowing precise positioning of the sample together with a constant elevated temperature of the sample for the whole period of the experiment. Soft uncoated AFM probes HYDRA-2R-100N (Applied NanoStructures, Mountain View, CA, USA), i.e. silicon nitride cantilevers with silicon tips are used for stiffness studies because they are maximally gentle to living cells (not causing mechanical stimulation). Moreover, as compared with coated cantilevers, these probes are very stable under elevated temperatures in liquids – thus allowing long-time measurements without nonspecific changes in the measured signal.</p> <p><em>Image analysis</em></p> <p>Fluorescence microscopy data were analyzed in ImageJ 1.52h and Python 3.7.1 as follows: cells were manually segmented using actin fluorescence channel, two regions were created for analysis: whole cell and cell periphery, lining a 4 μm thick region around cell border and including most of periphery actin cytoskeleton. In these two regions following parameters were measured for both actin and tubulin fluorescence: Integrated intensity, median intensity, and following regions were measured to describe cell morphology: Cell area, Maximum caliper (max feret diameter), roundness, and aspect ratio. Moreover, stress fibers were manually segmented in every cell and following parameters were measured: number of fibers per cell, feret angle of fiber, integrated intensity, fiber length, mean intensity. Next, a standard deviation of feret angles of individual fibers was calculated relatively to mean of feret angle using a circstd function from scipy package for Python.</p> <p><strong>Identification of files</strong></p> <p><em>Microscopy data</em></p> <p>Files are separated into individual zip files. The dataset of <em>confocal microscopy </em>is separated based on treatments: untreated control, docetaxel-treated cells, cisplatin-treated cells, zinc-treated cells. Filenames actin_tubulin_Zstack_cisplatin.zip, actin_tubulin_Zstack_untreated_control.zip, actin_tubulin_Zstack_zinc.zip, actin_tubulin_Zstack_docetaxel.zip. Files included in these ZIP archives are named as follows: "cellline_treatment_FOV". Files are 3-layer 16bit tiff files with layer sequence as follows: F-Actin (Phalloidin)/b-tubulin/Hoechst 33342. The dataset contains 242 FOVs of three cell line types/three treatments + one control, files are Z-stacks made of 50 slices.</p> <p>The dataset of <em>atomic force microscopy </em>(AFM) is included in one ZIP archive "AFM_YoungModulus_SetpointHeight.zip", which includes data on Young modulus and Setpoint Height of cell lines 22Rv1, PNT1A and PC-3 and treatments zinc, docetaxel, cisplatin (+control), i.e. identical like for confocal microscopy. The file naming is as follows: "AFM_cellline_treatment_FOV_Youngmodulus.tif" for Young modulus and "AFM_cellline_treatment_FOV_setpointheight.tif" for setpoint height. The data are filtered 32-bit tiff images, where the pixel value correspond to cell stiffness (young modulus) in Pa or setpoint height in m.</p> <p><em>Confocal microscopy analysis files</em></p> <p>Following files are csv tables including image analysis of actin/tubulin staining captured by confocal microscope:</p> <p>Cytoskeleton_fluo_analysis_Cell_Cell_periphery_morphology.csv: table includes analyzed data for actin and tubulin staining in following cellular regions: cell, cell periphery. Standard ImageJ parameters regarding intensity and morphology included.</p> <p>Cytoskeleton_fluo_analysis_Fibers.csv: table includes results of manual segmentation and consequent analysis of actin stres fibers in the cells. Apart from standard ImageJ parameters, also number of stress fibers per cell and standard deviation of fiber angle relative to the cell mean angle (for details see methods) are included.</p>
DWCox: A Density-Weighted Cox Model for Outlier-Robust Prediction of Prostate Cancer Survival
<p>This package, <strong>DWCox</strong>, implements a <strong>d</strong>ensity-<strong>w</strong>eighted <strong>Cox</strong> regression model that is more robust against outliers in the training data. DWCox gives more accurate predictions than the standard Cox regression on prostate cancer survival, especially in cases where the training data are expected to contain a lot of outliers. More details can be found in our paper (coming soon) and the README file inside this package.</p>
Differential DNA methylation in the benign and cancerous prostate tissue of African American and European American men
<p>The data presented here are the summary statistics for the manuscript, "Differential DNA methylation in the benign and cancerous prostate tissue of African American and European American men." The study aims to improve our understanding of prostate cancer disparities between African American and European American men by comparing the DNA methylation features that distinguish tumor and paired, histologically benign tissue from a sample of African American and European American prostate cancer patients. The summary statistics presented here represent the results of a differential methylation analyses comparing tumor and benign tissue in each ancestry group as well as the results of an analysis of differential methylation by ancestry group within each tissue. </p> <p>The files included are: </p> <p>AA_TumorvBenign_Dummy.zip which contains the results of the association analysis between tumor vs benign (benign as the default) tissue status and individual CpG sites in African Americans based on a model that accounts for the paired nature of samples using a series of dummy variables for individual. </p> <p>AA_TumorvBenign_MixedModel.zip which which contains the results of the association analysis between tumor vs benign (benign as the default) tissue status and individual CpG sites in African Americans based on a model that accounts for the paired nature of samples using a linear mixed model that included patient as a random effect. </p> <p>EA_TumorvBenign_Dummy.zip which contains the results of the association analysis between tumor vs benign (benign as the default) tissue status and individual CpG sites in European Americans based on a model that accounts for the paired nature of samples using a series of dummy variables for individual. </p> <p>EA_TumorvBenign_MixedModel.zip which which contains the results of the association analysis between tumor vs benign (benign as the default) tissue status and individual CpG sites in European Americans based on a model that accounts for the paired nature of samples using a linear mixed model that included patient as a random effect. </p> <p>Benign_AncestryCompare_Summary.zip which contains the results of an association analysis between ancestry designation (African American vs European American with African American as the baseline) and individual CpG sites in benign tissue. </p> <p>Tumor_AncestryCompare_Summary.zip which contains the results of an association analysis between ancestry designation (African American vs European American with African American as the baseline) and individual CpG sites in tumore tissue. </p>
Data of FigS7, "The Potential Tumor-Suppressor DHRS7 Inversely Correlates with EGFR Expression in Prostate Cancer Cells and Tumor Samples"
<p>Data of FigS7, “The Potential Tumor-Suppressor DHRS7 Inversely Correlates with EGFR Expression in Prostate Cancer Cells and Tumor Samples”</p> <p>The Dataset (original publication: doi: 10.3390/cancers14133074) contains the original figure as PNG-format (10.3390-cancers14133074_FigS7.PNG). The Corresponding raw data and subsequent data analysis obtained contains one file in txt-format (31003A-179400_10.3390-cancers14133074_SSDHRS7_23_1_M .txt) and one file as csv-format (31003A-179400_10.3390-cancers14133074_SSDHRS7_12_1.csv).</p>
Integration of expression datasets to identify biomarkers for accurate Gleason scoring in Prostate Cancer -- Supplementary data
<p>This dataset contains expression data from multiple sources used to identify biomarker candidates for prostate cancer aggressiveness. The data includes transcriptional expression levels, patient metadata, and other relevant features utilized in our machine-learning models. The training dataset was extracted from the repository described at Matos-Filipe, et al. (2022) [1].</p> <p>Raw ML metrics from models gaussian Naïve Bayes classifiers using this dataset are available in </p> <p> </p> <p>[1] <span><span><span>Matos-Filipe, P, et al. "</span></span></span>The usage of transcriptomics datasets as sources of Real-World Data for clinical trialling". <span>bioRxiv (</span><span>2022). </span><span><span>doi:</span> https://doi.org/10.1101/2022.11.10.515995</span></p>
Mammary single-cell RNA-seq analysis and prostate cancer survival as a function of H2AFJ expression for the paper entitled: The histone variant H2A.J is enriched in luminal epithelial cells
<p>H2A.J is a poorly studied mammalian-specific variant of histone H2A. We used immunohistochemistry to study its localization in various human and mouse tissues. H2A.J showed cell-type specific expression with a striking enrichment in luminal epithelial cells of multiple glands including those of breast, prostate, pancreas, thyroid, stomach, and salivary glands. H2A.J was also highly expressed in many carcinoma cell lines and in particular, those derived from luminal breast and prostate cancer. H2A.J thus appears to be a novel marker for luminal epithelial cancers. Knocking-out the H2AFJ gene in T47D luminal breast cancer cells reduced the expression of several estrogen-responsive genes which may explain its putative tumorigenic role in luminal-B breast cancer.</p>
distinct mesenchymal cell states mediate prostate cancer progression
<p>These are the count matrices (in .h5ad format) used to produce the results and figures in the paper entitled "distinct mesenchymal cell states mediate prostate cancer progression". </p><ul><li>adata_mouse.h5ad: the normalized count matrix and cell annotations for the mesenchymal prostate data from all mouse models.</li><li>adata_mouse_myo.h5ad: the normalized count matrix for the myofibroblasts and pericytes (both are c0).</li><li>scenic_mesenchyme_auc.csv: the auc matrix of the regulons activity in the different cells and clusters in the mouse mesenchymal data.</li><li>scenic_mesenchyme_binary.csv: the binary matrix of regulons activity in the mouse mesenchymal data.</li><li>adata_human.h5ad: the normalized count matrix and cell annotations for the mesenchymal human primary prostate cancer data.</li><li>adata_human_boneMet_stroma.h5ad: the normalized count matrix and cell annotation for the bone metastasis data derived from Kfoury et al.</li><li>visium_PRN.h5ad: the normalized count matrix and cell annotation for the Visium spatial transcriptomics data of the PRN mouse model.</li><li>visium_WT.h5ad: the normalized count matrix and cell annotation for the Visium spatial transcriptomics data of the WT (PRN-WT) mouse model.</li><li>natHistory_expression: the normalized expression matrix for the natural history cohort.</li><li>natHistory_label: the metastasis indicators for the natural history cohort.</li></ul>
Data of FigS2, "The Potential Tumor-Suppressor DHRS7 Inversely Correlates with EGFR Expression in Prostate Cancer Cells and Tumor Samples"
<p>Data of FigS2, “The Potential Tumor-Suppressor DHRS7 Inversely Correlates with EGFR Expression in Prostate Cancer Cells and Tumor Samples”</p> <p>The Dataset (original publication: doi: 10.3390/cancers14133074) contains the original figure as PNG-format (10.3390-cancers14133074_FigS2.PNG). The corresponding raw data and subsequent data analysis obtained from proteomics analysis are provided as nine files in CSV format (31003A-179400_10.3390-cancers14133074_SS_SA_DHRS7_5_1-3_M1-3.csv). All further experiment related information provided as one meta-data-file (31003A-179400_10.3390-cancers14133074_SS_SA_DHRS7_5_1_M .txt) in txt format.</p>
Data of FigS4, "The Potential Tumor-Suppressor DHRS7 Inversely Correlates with EGFR Expression in Prostate Cancer Cells and Tumor Samples"
<p>Data of FigS4, “The Potential Tumor-Suppressor DHRS7 Inversely Correlates with EGFR Expression in Prostate Cancer Cells and Tumor Samples”</p> <p>The Dataset (original publication: doi: 10.3390/cancers14133074) contains the original figure as PNG-format (10.3390-cancers14133074_FigS4.PNG). The Corresponding raw data and subsequent data analysis obtained from western blot analysis contains the original figures of the raw blots and antibody dilutions as PDF-format (31003A-179400_10.3390-cancers14133074_SSDHRS7_2_6_M1.pdf), data analysis (densitometry) and all further experiment related information provided as one meta-data-file in txt format (31003A-179400_10.3390-cancers14133074_SSDHRS7_2_6_M.txt) and three files in CSV-format (31003A-179400_10.3390-cancers14133074_SSDHRS7_2_6_1-3.csv).</p>
Data of Fig7, "The Potential Tumor-Suppressor DHRS7 Inversely Correlates with EGFR Expression in Prostate Cancer Cells and Tumor Samples"
<p>Data of Fig7, “The Potential Tumor-Suppressor DHRS7 Inversely Correlates with EGFR Expression in Prostate Cancer Cells and Tumor Samples”</p> <p>The Dataset (original publication: doi: 10.3390/cancers14133074) contains the original figure as PNG-format (10.3390-cancers14133074_Fig7.PNG). The Corresponding raw data and subsequent data analysis obtained for TCGA analysis contains one file in txt-format (31003A-179400_10.3390-cancers14133074_SSDHRS7_23_1_M.txt), and all further related information provided as one meta-data-file in pdf-format (31003A-179400_10.3390-cancers14133074_SSDHRS7_23_1_M1.pdf)</p> <p> </p>
Data of Fig8, "The Potential Tumor-Suppressor DHRS7 Inversely Correlates with EGFR Expression in Prostate Cancer Cells and Tumor Samples"
<p>Data of Fig8, “The Potential Tumor-Suppressor DHRS7 Inversely Correlates with EGFR Expression in Prostate Cancer Cells and Tumor Samples”</p> <p>The Dataset (original publication: doi: 10.3390/cancers14133074) contains the original figure as PNG-format (10.3390-cancers14133074_Fig8.PNG). The Corresponding raw data and subsequent data analysis obtained for immunohistochemistry contains one file in txt-format (31003A-179400_10.3390-cancers14133074_SSDHRS7_12_1_M .txt) and one file in csv-format (31003A-179400_10.3390-cancers14133074_SSDHRS7_12_1.csv), and all further related information provided as one meta-data-file in pdf-format (31003A-179400_10.3390-cancers14133074_SSDHRS7_12_1_M1 .pdf)</p> <p> </p>
Data of Fig4, "The Potential Tumor-Suppressor DHRS7 Inversely Correlates with EGFR Expression in Prostate Cancer Cells and Tumor Samples"
<p>Data of Fig4, “The Potential Tumor-Suppressor DHRS7 Inversely Correlates with EGFR Expression in Prostate Cancer Cells and Tumor Samples”</p> <p>The Dataset (original publication: doi: 10.3390/cancers14133074) contains the original figure as PNG-format (10.3390-cancers14133074_Fig4.PNG). The Corresponding raw data and subsequent data analysis obtained from western blot analysis contains the original figures of the raw blots and antibody dilutions as PDF-format (31003A-179400_10.3390-cancers14133074_SSDHRS7_2_3_M_1.pdf), data analysis (densitometry) and all further experiment related information provided as one meta-data-file in txt format (31003A-179400_10.3390-cancers14133074_SSDHRS7_2_3_M.txt). Corresponding raw data and subsequent data analysis obtained from RT-PCR analysis provided as one files in TXT format (31003A-179400_10.3390-cancers14133074_SSDHRS7_1_4_M.txt), all further experiment related information provided as one meta-data-file in pdf format (31003A-179400_10.3390-cancers14133074_SSDHRS7_1_4_M_1.pdf).</p>
Data of Fig2, "The Potential Tumor-Suppressor DHRS7 Inversely Correlates with EGFR Expression in Prostate Cancer Cells and Tumor Samples"
<p>Data of Fig2, “The Potential Tumor-Suppressor DHRS7 Inversely Correlates with EGFR Expression in Prostate Cancer Cells and Tumor Samples”</p> <p>The Dataset (original publication: doi: 10.3390/cancers14133074) contains the original figure as PNG-format (10.3390-cancers14133074_Fig2.PNG). The corresponding raw data and subsequent data analysis obtained from proteomics analysis are provided as three files in CSV format (31003A-179400_10.3390-cancers14133074_SS_SA_DHRS7_5_1-3.csv). All further experiment related information provided as one meta-data-file (31003A-179400_10.3390-cancers14133074_SS_SA_DHRS7_5_1_M .txt) in txt format. Corresponding raw data and subsequent data analysis obtained from western blot analysis contains the original figures of the raw blots and antibody dilutions as PDF-format (31003A-179400_10.3390-cancers14133074_SSDHRS7_2_1_M_1 .pdf), data analysis (densitometry) and all further experiment related information provided as one meta-data-file in txt format (31003A-179400_10.3390-cancers14133074_SSDHRS7_2_1_M.txt). Corresponding raw data and subsequent data analysis obtained from RT-PCR analysis provided as one files in TXT format (31003A-179400_10.3390-cancers14133074_SSDHRS7_1_2_M.txt), all further experiment related information provided as one meta-data-file in pdf format (31003A-179400_10.3390-cancers14133074_SSDHRS7_1_2_M_1.pdf).</p>
Data of Fig5, "The Potential Tumor-Suppressor DHRS7 Inversely Correlates with EGFR Expression in Prostate Cancer Cells and Tumor Samples"
<p>Data of Fig5, “The Potential Tumor-Suppressor DHRS7 Inversely Correlates with EGFR Expression in Prostate Cancer Cells and Tumor Samples”</p> <p>The Dataset (original publication: doi: 10.3390/cancers14133074) contains the original figure as PNG-format (10.3390-cancers14133074_Fig5.PNG). The Corresponding raw data and subsequent data analysis obtained from western blot analysis contains the original figures of the raw blots and antibody dilutions as PDF-format (31003A-179400_10.3390-cancers14133074_SSDHRS7_2_4_M_1.pdf), data analysis (densitometry) and all further experiment related information provided as one meta-data-file in txt format (31003A-179400_10.3390-cancers14133074_SSDHRS7_2_4_M.txt) and three files in CSV-format (31003A-179400_10.3390-cancers14133074_SSDHRS7_2_4_3.csv). Corresponding raw data and subsequent data analysis obtained from RT-PCR analysis provided as one files in TXT format (31003A-179400_10.3390-cancers14133074_SSDHRS7_1_5_M .txt) and three files in CSV format (31003A-179400_10.3390-cancers14133074_SSDHRS7_1_5-1-3.csv), all further experiment related information provided as three meta-data-files in pdf format (31003A-179400_10.3390-cancers14133074_SSDHRS7_1_5_M_1-3.pdf).</p>
Data of Fig6, "The Potential Tumor-Suppressor DHRS7 Inversely Correlates with EGFR Expression in Prostate Cancer Cells and Tumor Samples"
<p>Data of Fig6, “The Potential Tumor-Suppressor DHRS7 Inversely Correlates with EGFR Expression in Prostate Cancer Cells and Tumor Samples”</p> <p>The Dataset (original publication: doi: 10.3390/cancers14133074) contains the original figure as PNG-format (10.3390-cancers14133074_Fig6.PNG). The Corresponding raw data and subsequent data analysis obtained from western blot analysis contains the original figures of the raw blots and antibody dilutions as PDF-format (31003A-179400_10.3390-cancers14133074_SSDHRS7_2_5_M1.pdf), data analysis (densitometry) and all further experiment related information provided as one meta-data-file in txt format (31003A-179400_10.3390-cancers14133074_SSDHRS7_2_5_M.txt) and three files in CSV-format (31003A-179400_10.3390-cancers14133074_SSDHRS7_2_5_1-3.csv).</p> <p> </p>
Data of Fig3, "The Potential Tumor-Suppressor DHRS7 Inversely Correlates with EGFR Expression in Prostate Cancer Cells and Tumor Samples"
<p>Data of Fig3, “The Potential Tumor-Suppressor DHRS7 Inversely Correlates with EGFR Expression in Prostate Cancer Cells and Tumor Samples”</p> <p>The Dataset (original publication: doi: 10.3390/cancers14133074) contains the original figure as PNG-format (10.3390-cancers14133074_Fig3.PNG). The Corresponding raw data and subsequent data analysis obtained from western blot analysis contains the original figures of the raw blots and antibody dilutions as PDF-format (31003A-179400_10.3390-cancers14133074_SSDHRS7_2_2_M_1.pdf), data analysis (densitometry) and all further experiment related information provided as one meta-data-file in txt format (31003A-179400_10.3390-cancers14133074_SSDHRS7_2_2_M.txt). Corresponding raw data and subsequent data analysis obtained from RT-PCR analysis provided as one files in TXT format (31003A-179400_10.3390-cancers14133074_SSDHRS7_1_3_M.txt), all further experiment related information provided as one meta-data-file in pdf format (31003A-179400_10.3390-cancers14133074_SSDHRS7_1_3_M_1.pdf).</p>
Data of Fig1, "The Potential Tumor-Suppressor DHRS7 Inversely Correlates with EGFR Expression in Prostate Cancer Cells and Tumor Samples"
<p>Data of Fig1, “The Potential Tumor-Suppressor DHRS7 Inversely Correlates with EGFR Expression in Prostate Cancer Cells and Tumor Samples”</p> <p>The Dataset (doi: 10.3390/cancers14133074) contains the original figures as PNG-format (10.3390-cancers14133074_Fig1.PNG). Raw data and related Meta data are provides as one file in TXT format (31003A-179400_10.3390-cancers14133074_SSDHRS7_1_1_M.txt) and one file in PDF-Format (31003A-179400_10.3390-cancers14133074_SSDHRS7_1_1_M_1.pdf).</p>
Data of Fig9, "The Potential Tumor-Suppressor DHRS7 Inversely Correlates with EGFR Expression in Prostate Cancer Cells and Tumor Samples"
<p>Data of Fig9, “The Potential Tumor-Suppressor DHRS7 Inversely Correlates with EGFR Expression in Prostate Cancer Cells and Tumor Samples”</p> <p>The Dataset (original publication: doi: 10.3390/cancers14133074) contains the original figure as PNG-format (10.3390-cancers14133074_Fig9.PNG). The Corresponding raw data and subsequent data analysis obtained for immunohistochemistry contains one file in txt-format (31003A-179400_10.3390-cancers14133074_SSDHRS7_12_1_M.pdf) and one file in csv-format (31003A-179400_10.3390-cancers14133074_SSDHRS7_12_1.csv), and all further related information provided as one meta-data-file in pdf-format (31003A-179400_10.3390-cancers14133074_SSDHRS7_23_1_M .txt)</p> <p> </p>
Data of FigS3, "The Potential Tumor-Suppressor DHRS7 Inversely Correlates with EGFR Expression in Prostate Cancer Cells and Tumor Samples"
<p>Data of FigS3, “The Potential Tumor-Suppressor DHRS7 Inversely Correlates with EGFR Expression in Prostate Cancer Cells and Tumor Samples”</p> <p>The Dataset (original publication: doi: 10.3390/cancers14133074) contains the original figure as PNG-format (10.3390-cancers14133074_FigS3.PNG). The Corresponding raw data and subsequent data analysis obtained for TCGA analysis contains one file in txt-format (31003A-179400_10.3390-cancers14133074_SSDHRS7_23_3_M .txt), six files in csv-format (31003A-179400_10.3390-cancers14133074_SSDHRS7_23_3-1-6 .csv) and one file in sps-format (31003A-179400_10.3390-cancers14133074_SSDHRS7_23_3-4 .sps). All further related information provided as one meta-data-file in pdf-format (31003A-179400_10.3390-cancers14133074_SSDHRS7_23_2_M 1.pdf).</p>
Data of FigS5, "The Potential Tumor-Suppressor DHRS7 Inversely Correlates with EGFR Expression in Prostate Cancer Cells and Tumor Samples"
<p>Data of FigS5, “The Potential Tumor-Suppressor DHRS7 Inversely Correlates with EGFR Expression in Prostate Cancer Cells and Tumor Samples”</p> <p>The Dataset (original publication: doi: 10.3390/cancers14133074) contains the original figure as PNG-format (10.3390-cancers14133074_FigS5.PNG). The Corresponding raw data and subsequent data analysis obtained from western blot analysis contains the original figures of the raw blots and antibody dilutions as PDF-format (31003A-179400_10.3390-cancers14133074_SSDHRS7_2_7_M1.pdf), data analysis (densitometry) and all further experiment related information provided as one meta-data-file in txt format (31003A-179400_10.3390-cancers14133074_SSDHRS7_2_7_M.txt).</p> <p> </p>
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.